Clinical Trial Update: Spexin and Phoenixin-20 in Girls With Central Precocious Puberty

View source ↗

Summary

A completed clinical trial evaluating spexin and phoenixin-20 in girls with Central Precocious Puberty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty
• Hypothalamic-pituitary-ovarian Axis Dysfunction
• Puberty Disorders

Drugs mentioned

• Phoenixin-20 (Phoenixin-20)
• Spexin (Spexin)

Snippet

Sponsor: Kayseri City Hospital | Conditions: Central Precocious Puberty (CPP), Puberty Disorders | Status: COMPLETED